Coronary artery disease is the leading cause of death worldwide. Determining the coronary artery developmental program could aid understanding of the disease and lead to new treatments, but many aspects of the process, including their developmental origin, remain obscure. Here we show, using histological and clonal analysis in mice and cardiac organ culture, that coronary vessels arise from angiogenic sprouts of the sinus venosus-the vein that returns blood to the embryonic heart. Sprouting venous endothelial cells dedifferentiate as they migrate over and invade the myocardium. Invading cells differentiate into arteries and capillaries; cells on the surface redifferentiate into veins. These results show that some differentiated venous cells retain developmental plasticity, and indicate that position-specific cardiac signals trigger their dedifferentiation and conversion into coronary arteries, capillaries and veins. Understanding this new reprogramming process and identifying the endogenous signals should suggest more natural ways of engineering coronary bypass grafts and revascularizing the heart.
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Coronary artery disease is the leading cause of death worldwide. Determining the coronary artery developmental program could aid understanding of the disease and lead to new treatments, but many aspects of the process, including their developmental origin, remain obscure. Here we show, using histological and clonal analysis in mice and cardiac organ culture, that coronary vessels arise from angiogenic sprouts of the sinus venosus-the vein that returns blood to the embryonic heart. Sprouting venous endothelial cells dedifferentiate as they migrate over and invade the myocardium. Invading cells differentiate into arteries and capillaries; cells on the surface redifferentiate into veins. These results show that some differentiated venous cells retain developmental plasticity, and indicate that position-specific cardiac signals trigger their dedifferentiation and conversion into coronary arteries, capillaries and veins. Understanding this new reprogramming process and identifying the endogenous signals should suggest more natural ways of engineering coronary bypass grafts and revascularizing the heart.
There has been tremendous progress during the past two decades in elucidating the general principles of blood vessel development and the factors that control it [1] [2] [3] [4] , especially during tumour angiogenesis 5, 6 . Comparatively little is known, however, about the cellular origins and developmental programs of many of our most important vessels and vascular beds, such as the coronary arteries that supply the heart muscle (myocardium) and its pacemaker [7] [8] [9] . Seven million people die each year of coronary artery disease and its sequelae, myocardial infarction and cardiac arrest, making it the leading cause of death worldwide 10 . Tens of millions of others manage the disease medically or undergo major interventions such as angioplasty or coronary bypass surgery 10 . Determining how coronary vessels arise during development and are maintained in adult life, and how they are remodelled under pathological conditions such as arteriosclerosis, should further our understanding of the disease. It could also lead to new treatments that stimulate vessel growth, and new ways of engineering bypass grafts with the flow properties and durability of healthy young vessels.
The development of coronary arteries has been studied in a variety of animals for more than a century. Early anatomical studies in humans and other mammals suggested that they bud from the aorta [11] [12] [13] [14] . More recent experiments with chick-quail chimaeras argued against this and suggested instead that they arise from the proepicardium, a transitory structure in the embryo that contacts and spreads over the developing heart to form its epithelial covering (epicardium) and several internal tissues [15] [16] [17] . The chick experiments and subsequent studies led to the current textbook view that coronary vessels form from proepicardial cells that undergo an epithelial-to-mesenchymal transition, and then differentiate into isolated endothelial progenitors that assemble de novo ('vasculogenesis') into endothelial tubes 7, 18 . However, not all data from chick is easily reconciled with this model 9, 19 , and recent lineage-tracing experiments in mouse show that, although the proepicardium gives rise to myocardial stroma and vascular smooth muscle, it gives rise to few, if any coronary endothelial cells [20] [21] [22] [23] . Thus, the origin of coronary artery endothelial cells, which are among the most medically important cells in the body, remains an enigma.
Here we use histological and clonal analysis in mouse, and cardiac organ culture, to investigate the origins and early development of coronary arteries. The results show that coronary arteries do not derive from the proepicardium but from endothelial sprouts of the sinus venosus-the venous inflow tract of the embryonic heartwith a small contribution from endocardium lining the cardiac chambers. The patterns of migration and marker expression of the venous sprouts suggest a model in which local signals in the developing heart induce angiogenic outgrowth, dedifferentiation, and stepwise conversion into coronary arteries, capillaries and veins.
Histological analysis of coronary development
We carried out a thorough anatomical and histological analysis of coronary vessel development during mouse embryogenesis using endothelial markers ( Fig. 1 and Supplementary Fig. 1 ). Because canonical endothelial markers also label endocardial cells and can thus complicate the analysis ( Supplementary Fig. 2 ), we used an apelin-nlacZ knock-in mouse strain 24 that selectively expresses nuclear b-galactosidase in coronary endothelial cells but not in endocardium ( Supplementary Fig. 3 ). X-gal staining showed an expanding vascular plexus on the heart beginning at embryonic day (E) 11.5 ( Fig. 1a-j) , indistinguishable from that detected by CD31 (also known as PECAM1) immunostaining ( Supplementary Fig. 2 ) 25, 26 . The plexus originated on the dorsal cardiac surface (Fig. 1a) , and expanded around the atrioventricular canal (Fig. 1b) to reach the outflow tract (Fig. 1d, f) and invade the ventral interventricular groove (Fig. 1f) . It also expanded caudally (Fig. 1c, e) , populating the entire dorsal surface by E14.5 (Fig. 1g) ; during this period (E12.5-14.5), dorsal plexus sprouts invaded the underlying myocardium ( Supplementary Fig. 1 ). Larger diameter coronary arteries appeared within the myocardium at E14.5 and subsequently matured (Fig. 1k, l,  r) . By E15.5, the entire ventral surface was also covered with plexus ( Fig. 1j) , and coronary veins began to appear on the dorsal surface (Fig. 1i ). There were also isolated clusters of endothelial cells surrounding blood cells, including erythrocytes (TER119
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, also known as LY76 Close inspection of the site where the plexus originated (Fig. 1a , m-o) suggested that the source of endothelial cells is the sinus venosus. Vessels extending from the sinus venosus expressed apelin and three other angiogenic sprout markers [28] [29] [30] [31] (Vegfr3 (also known as Flt4), Dll4 and Pdgfb) (Fig. 1p, q and data not shown), supporting an angiogenic origin. These sprouts grew through the inflow tract myocardium and onto the cardiac surface, traversing a stereotyped path as they extended to invest the heart (Fig. 1n, s) . Apart from these sprouts and adjacent liver plexus, we did not detect any endothelial cells in or associated with the proepicardium ( Supplementary Fig. 4 ), nor did we detect any proepicardial cells that became sinus venosus or other endothelial cells by Tbx18-Cre lineage tracing ( Supplementary Fig. 5 ). We also detected only extremely rare VEGFR2

CD31
2 cells-putative endothelial progenitors ('angioblasts') that are abundant around vessels forming by vasculogenesis in other body regions 32 -in the proepicardium or heart wall ( Supplementary Fig. 6 ). Thus, coronary vessel progenitors seem to arise from sinus venosus angiogenic sprouts, not from the proepicardium or other vasculogenic sources.
Analysis of coronary origins in vitro
We tested the sinus venosus sprouting model in two ways. First, the origins and requirements for coronary sprouting were analysed in a cardiac organ culture system 26 modified to allow tissue recombination experiments (see Methods). Developing hearts were isolated from apelin-nLacZ mice at E10.5, after the proepicardium has spread over the heart surface to form the epicardium but before any coronary sprouts are present. Hearts were either left intact or dissected to separate the ventricles with their epicardial covering (V/Epi) from sinus venosus and atria (SV/A), and then cultured for 72 h and stained for coronary endothelial markers (apelin-nlacZ or CD31) to determine whether coronary vessels had formed (Fig. 2) . All of the dissected chambers (n 5 39) appeared healthy and continued to beat throughout the culture period, as did control hearts that were left intact (n 5 24) (Supplementary Movies 1-4). However, whereas coronary sprouts formed in 22 out of 24 (92%) intact control hearts, none developed when the V/Epi (n 5 30) or SV/A (n 5 9) was cultured alone (Fig. 2a-c, f) . In tissue recombination experiments in which a dissected SV/A from apelin-nlacZ transgenic mice was recombined with a wild-type (non-transgenic) V/Epi, coronary vessels formed on the V/Epi and expressed the apelin-nlacZ transgene ( Fig. 2d; 13 of 20,  65% ). By contrast, no coronary vessels expressing the transgene . Inset in h is close-up of boxed blood island-like structure. la, left atrium; lv, left ventricle; ra, right atrium; rv, right ventricle. Scale bar, 200 mm (for a-l). k, X-gal-stained E15.5 ephrinB2-lacZ heart (right lateral (rl) view) showing right coronary artery (rca, arrowhead). ao, aorta. l, Angiogram of E15.5 heart showing right coronary artery (arrowhead). m, Frontal section through E11.5 heart immunostained for VE-cadherin. Coronary sprouts (green, arrowheads) are continuous with the sinus venosus (sv; above dashed line). Inset is close-up of boxed region showing junction between sinus venosus and coronary sprouts. Scale bar, 100 mm. n, Sagittal section (approximate section plane shown in c) through E12.5 heart stained for CD31 (green) and with the nuclear dye DAPI (blue). Coronary sprout (dotted line) extends from the sinus venosus and courses around right atrium to reach right ventricle. o, Close-up of coronary sprout in n. p, q, Adjacent sections from E11.5 heart immunostained for CD31 (p) and probed for Vegfr3 messenger RNA (purple) (q). Coronary vessels (dotted line) express Vegfr3, an angiogenic sprout marker, whereas vessels formed by vasculogenesis (sinus venosus, atria, outflow tract) do not (arrowheads). Inset in q is close-up of boxed region. Scale bar, 200 mm (for n, p, q). r, Schematic of right and left (lca) coronary arteries and coronary veins (cv) at E15.5. Arrows show blood flow direction. s, Schematic sagittal sections showing coronary sprout (blue) progression during development. epi, epicardium; is, invading sprouts; ss, superficial sprouts; svs, sinus venosus sprouts.
developed when a wild-type SV/A was cultured with an apelin-nlacZ V/Epi ( Fig. 2e; n 5 5) . Hence, apelin-nlacZ 1 coronary vessels arise from the dissected SV/A tissue, not the epicardial cells or other proepicardial derivatives in the dissected V/Epi, but they require signals provided by the V/Epi for sprouting and outgrowth.
Clonal analysis of coronary development
We next tested the sinus venosus sprouting model by clonal analysis, which allowed us to map the origin and determine the proliferation rate, outgrowth pathway, and fate of coronary endothelial progenitors in vivo. We used a VE-cadherin-CreER transgene that expresses a tamoxifen-inducible Cre recombinase 33 , in combination with Credependent marker genes (see Methods), to permanently label individual endothelial cells and their descendants. Recombination was induced by tamoxifen administration between E7.5 and E9.5 and analysed 4-7 days later. Limiting doses of tamoxifen were used, and hearts with a single cluster of marked cells (putative clone) or two or three well-isolated clusters were analysed (Fig. 3a, b) . A multicolour Cre-dependent marker similar to Brainbow 34 was used to confirm clonality of clusters (Fig. 3c-h ). The endothelial cell proliferation rate estimated from the clonal analysis (Supplementary Table 1 ) was 6-19 h for nearly all (23 of 25) of the endothelial clones.
The clonal analysis (Supplementary Table 1 and Supplementary  Fig. 7 ) established two key aspects of the sinus venosus sprouting model. First, because coronary endothelial clones were consistently obtained after early (E7.5) induction of VE-cadherin-CreER, coronary artery progenitors must arise from differentiated (VE-cadherin 1 ) endothelial cells present at this age. This is the result expected from the sinus venosus sprouting model, and it argues against a proepicardial origin because no VE-cadherin 1 cells other than sinus venosus sprouts and liver plexus are associated with the proepicardial organ ( Supplementary Fig. 4) . Second, most coronary artery cells are clonally related to sinus venosus cells. In total, 25 out of 34 coronary endothelial clones, and all 20 that contained more than 85 coronary endothelial cells, had labelled sister cells within the sinus venosus (Fig. 3a, c- Supplementary Fig. 7 ). These clones spanned the coronary plexus from the sinus venosus at the dorsal side of the heart, where plexus formation begins, to the growing front of the plexus ( Supplementary Fig. 7, type I) . The longer the period between clone induction and analysis, the farther the clones extended from the sinus venosus, consistent with a sinus venosus origin. At the latest times examined, clones included endothelial cells of coronary arteries, veins and capillaries, demonstrating that a single labelled cell can be reprogrammed to form not just coronary artery but all three types of coronary endothelial cells (Fig. 3e and Supplementary Table 1) .
The clonal analysis revealed a minor secondary source of coronary endothelial cells. The nine coronary endothelial clones that did not contain any sinus venosus sister cells each contained sister cells in a patch of ventricular (8 out of 9) or atrial (1 out of 9) endocardium (Fig. 3b, f-h and Supplementary Table 1) . The presence of blood island-like structures in four of the ventricular clones, and their location near the interventricular groove, indicate that they correspond to the endothelial blood islands noted earlier in the histological analysis ( Fig. 1h and Supplementary Fig. 2 ). Thus, this population of endocardium-derived coronary endothelial cells may form by endocardial budding through the myocardium, pinching-off and forming endothelial spheres with entrapped blood cells (blood islands) that later join the sinus-venosus-derived plexus. In support of this, we identified putative intermediates in which endocardial buds were seen penetrating the myocardium (Fig. 3i) , and blood islands were caught joining the coronary plexus (Fig. 3j) .
Marker expression during venous reprogramming
The experiments described establish that coronary artery progenitors arise primarily from VE-cadherin 1 cells that sprout from the sinus venosus and migrate over the heart and into the myocardium as they become coronary arteries. Because the path is stereotyped, we could analyse molecular transitions during the process. Marker analysis showed that sprouting sinus venosus cells, like other sinus venosus cells, are initially differentiated (EphB4-lacZ and COUP-TF2 1 (also known as Nr2f2 1 )) venous cells. But as they extend out from the sinus venosus, expression of the markers rapidly declines and venous identity is lost (Fig. 4a, e and Supplementary Fig. 8 ). A day later (E12.5), vessels that have invaded the myocardium begin to express ephrinB2-lacZ (Fig. 4c ) 35 and other arterial markers (Dll4, Hey1, Notch4 and Depp (also known as 8430408G22Rik)) ( Supplementary Fig. 9 ), and subsequently assemble into mature coronary arteries ( Fig. 4d and Supplementary Fig. 9 ). Vessels that remain superficial turn on EphB4-lacZ (Fig. 4b ) 35 and other venous markers (Vegfr3, Np2, Aplnr and COUP-TF2) as they form mature coronary veins (Supplementary Fig. 9 ).
Discussion
Our results resolve the century-old enigma of the origin of coronary arteries and demonstrate two surprising sources of progenitors and a new program of arteriogenesis. The major source is differentiated venous endothelial cells of the sinus venosus, which sprout onto the developing heart. There they dedifferentiate, proliferate and spread to form the coronary plexus, and subsequently redifferentiate and remodel into coronary arteries, capillaries and veins ( Supplementary Fig. 10) . A minor secondary source is the endocardium, from which cells separate to form blood islands and then join the coronary plexus near the interventricular septum. Our data do not exclude rare contributions from other sources, or distinct origins in other species such as chick.
Coronary sprouts follow a specific outgrowth path, and dedifferentiation and specific redifferentiation events occur at stereotyped times and positions. This suggests that local signals along the outgrowth path function not only as sprout inducers and guidance cues, but also serve to sequentially deprogram sinus venosus venous endothelial cells and reprogram them to coronary artery, venous and capillary fates (Supplementary Fig. 10 ). Our results demonstrate that differentiated venous cells can give rise to arterial vessels 36 , and we speculate that other organ-specific vascular beds, such as those of the retina and kidney, form in a similar manner: by developmental reprogramming of differentiated venous cells. Indeed, at least some venous cells in other parts of the body seem to retain plasticity because they can give rise to lymphatic vessels during development 4 . Furthermore, experimental manipulations such as flow reversal 37 and transplantation 38, 39 have been shown to alter the identity of embryonic venous cells, and adult saphenous veins used in coronary bypass grafts downregulate venous markers 40 . However, venous grafts do not acquire a full arterial phenotype 40 , which probably contributes to their lower success rate compared to arterial grafts 41, 42 . venous markers and induction of arterial markers during coronary artery development. a, Sagittal section through heart of E11.5 EphB4-lacZ embryo immunostained for CD31 (green) and b-gal (EphB4-lacZ, red). Coronary sprouts (dotted line) downregulate EphB4-lacZ as they migrate away from sinus venosus. liv, liver. Scale bar, 100 mm. b, E15.5 EphB4-lacZ heart. Vessels on surface (epicardium) have reacquired EphB4-lacZ expression. Scale bar, 200 mm. c, Sagittal section through E12.5 ephrinB2-lacZ heart. Coronary sprouts that have invaded myocardium (green, arrowheads) upregulate artery/capillary marker ephrinB2-lacZ (red), whereas surface vessels (green, dashed line at left) do not. d, E15.5 ephrinB2-lacZ heart. ephrinB2-lacZ is expressed by all arteries and capillaries within myocardium but not by surface vessels. Scale bar, 100 mm. e, Quantification of EphB4-lacZ expression in coronary sprouts budding from sinus venosus at E11.5. Values are from doublestained hearts as in a, normalized to CD31 staining at the same position. Identification of the endogenous signals that control coronary artery development, especially the dedifferentiation and reprogramming factors, would begin to explain the molecular basis of this new developmental process and suggest more natural ways of inducing new coronary vessels and engineering bypass grafts.
METHODS SUMMARY
Wild-type (CD1) and transgenic marker, Cre recombinase, and Cre reporter mouse strains are described in Methods. Staged embryos and hearts from timed pregnancies (the morning of vaginal plug was designated E0.5) were dissected and fixed in 4% paraformaldehyde and stored in PBS. Fixed tissues were left intact or sectioned, and then processed for whole-mount histochemistry (X-gal), immunohistochemistry, indirect or direct immunofluorescence, and RNA in situ hybridization with digoxigenin-labelled antisense probes as described in Methods. Specimens were imaged on a stereomicroscope (whole-mount tissue) or fluorescence compound or confocal microscopes (tissue sections); images were digitally captured and processed.
For organ culture, dissected hearts from E10.5 or E11 wild-type or apelinnlacZ embryos were placed on polycarbonate filters at the air-liquid interface of DMEM media with supplements. Some hearts were cultured intact; others were dissected into SV/A and ventricle and the fragments cultured alone or recombined with an SV/A contacting a ventricle. Cultures were maintained at 37 uC and 5% CO 2 for 72 h, then fixed and subjected to whole-mount X-gal staining to detect apelin-nlacZ 1 vessels. For clonal analysis, VE-cadherin-CreER mice were crossed to Rosa-lacZ or multicolour Cre recombination reporters. At E7.5, E8.5 or E9.5, dams received intraperitoneal injections of low tamoxifen doses to activate CreER and induce rare recombination events, generating single or well-separated clones of endothelial cells that constitutively express b-galactosidase (Rosa-lacZ) or one of three different fluorescent proteins (multicolour). At E13.5 or E14.5, embryos were dissected, fixed and stained to visualize the marked endothelial clones: embryos carrying Rosa-lacZ were stained with X-gal and the endothelial-specific antibody anti-CD31, and multicolour embryos were sectioned and stained with 49,6-diamidino-2-phenylindole (DAPI) or anti-CD31 antibody, and analysed with fluorophore-specific filters.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
